HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular genetic and bile acid profiles in two Japanese patients with 3beta-hydroxy-DELTA5-C27-steroid dehydrogenase/isomerase deficiency.

Abstract
We report definitive diagnosis and effective chenodeoxycholic acid (CDCA) treatment of two Japanese children with 3[beta]-hydroxy-[DELTA]5-C27-steroid dehydrogenase/isomerase deficiency. Findings of cholestasis with normal serum [gamma]-glutamyltransferase activity and total bile acid concentration indicated the need for definitive bile acid analysis. Large amounts of 3[beta]-hydroxy-[DELTA]5 bile acids were detected by gas chromatography-mass spectrometry. HSD3B7 gene analysis using peripheral lymphocyte genomic DNA from the patients and their parents identified four novel mutations of the HSD3B7 gene in the patients. One had a homozygous mutation, 314delA; the other had compound heterozygous mutations: V132F, T149I, and 973_974insCCTGC. Interestingly, the second patient's mother had V132F and T149I mutations in one allele. Excessive 3[beta]-hydroxy-[DELTA]5-bile acids such as 3[beta],7[alpha]-dihydroxy- and 3[beta],7[alpha],12[alpha]-trihydroxy-5-cholenoic acids were detected in the first patient's urine; the second patient's urine contained large amounts of 3[beta]-hydroxy-5-cholenoic acid. Liver dysfunction in both patients decreased with ursodeoxycholic acid treatment, but unusual bile acids were still detected. Normalization of the patients' liver function and improvement of bile acid profiles occurred with CDCA treatment. Thus, we found mutations in the HSD3B7 gene accounting for autosomal recessive neonatal cholestasis caused by 3[beta]-hydroxy-[DELTA]5-C27-steroid dehydrogenase/isomerase deficiency. Early neonatal diagnosis permits initiation of CDCA treatment at this critical time, before the late cholestatic stage.
AuthorsTatsuki Mizuochi, Akihiko Kimura, Isao Ueki, Tomoyuki Takahashi, Takuji Hashimoto, Akira Takao, Yoshitaka Seki, Hajime Takei, Hiroshi Nittono, Takao Kurosawa, Toyojiro Matsuishi
JournalPediatric research (Pediatr Res) Vol. 68 Issue 3 Pg. 258-63 (Sep 2010) ISSN: 1530-0447 [Electronic] United States
PMID20531254 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Bile Acids and Salts
  • DNA Primers
  • Chenodeoxycholic Acid
  • 3-Hydroxysteroid Dehydrogenases
  • 3 beta-hydroxy-delta 5-C(27)-steroid dehydrogenase
Topics
  • 3-Hydroxysteroid Dehydrogenases (deficiency, genetics)
  • Base Sequence
  • Bile Acids and Salts (urine)
  • Chenodeoxycholic Acid (pharmacology, therapeutic use)
  • Cholestasis (diagnosis, drug therapy, enzymology)
  • DNA Primers (genetics)
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Newborn, Diseases (diagnosis, drug therapy, enzymology)
  • Japan
  • Liver (drug effects, physiopathology)
  • Male
  • Molecular Sequence Data
  • Mutation (genetics)
  • Sequence Analysis, DNA

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: